TEVA Pharmaceuticals USA Issues Statement on a Statement by U.S. Department of Health and Human Services Secretary Kathleen Sebelius

NORTH WALES, Pa.--(BUSINESS WIRE)--We commend the FDA for making the recommendation to approve providing women with increased over-the-counter (OTC) access to Plan B One-StepĀ® and we are disappointed that at this late date, the Department of Health and Human Services has come to a different conclusion. We have not yet received the Complete Response Letter at this time. We will review the letter when we receive it and then determine our next steps.

Back to news